Thus, the ER/PR-negative subgroup united the subgroups of basal-like and non-luminal breast cancer, while the ER/PR-positive subgroup united the luminal subtypes of breast cancer (Supplementary Tables S1 and S2). This evidence concerns the gene ESR1 and breast carcinoma.